The Corporate Governance team at Clene Nanomedicine oversees the company's strategic direction and ensures compliance with regulatory standards. Composed of a diverse group of board members, this team is responsible for guiding corporate policies, fostering ethical practices, and safeguarding shareholder interests, all while supporting Clene's mission to develop innovative therapeutics for neurodegenerative diseases.
View all